PO-348 Two novel synthetic analogues of miR-1207–3 p, NB5 and NB1207, target AR-V7 and c-MYC and demonstratein vivotherapeutic efficacy in metastatic castrate-resistant prostate cancer (mcrpc) (original) (raw)

The long noncoding RNA sONE represses triple‐negative breast cancer aggressiveness through inducing the expression of miR‐34a, miR‐15a, miR‐16, and let‐7a

Rana A Youness

Journal of Cellular Physiology

View PDFchevron_right

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer

Naohiko Seki

British Journal of Cancer, 2017

View PDFchevron_right

Recent updates on the role of microRNAs in prostate cancer

Aamir Ahmad

Journal of Hematology & Oncology, 2012

View PDFchevron_right

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

Yuichiro Tanaka

Clinical Cancer Research, 2011

View PDFchevron_right

A systematic method introduced a common lncRNA-miRNA-mRNA network in the different stages of prostate cancer

tayebeh rastegar

Frontiers in Oncology, 2023

View PDFchevron_right

miR-204 is dysregulated in metastatic prostate cancer in vitro

Diana Zasheva

Molecular Carcinogenesis, 2015

View PDFchevron_right

Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer

Stéphanie Combe

Oncogene, 2019

View PDFchevron_right

THE MIR-15A/MIR-16-1 CLUSTER CONTROLS PROSTATE CANCER PROGRESSION CONTROL BY TARGETING OF MULTIPLE ONCOGENIC ACTIVITIES

A. Addario, Giovanni Muto

The Journal of Urology, 2009

View PDFchevron_right

THE MIR-15A/MIR-16-1 CLUSTER CONTROLS PROSTATE CANCER PROGRESSION BY TARGETING MULTIPLE ONCOGENIC ACTIVITIES

Giovanni Muto

Eur Urol Suppl, 2008

View PDFchevron_right

miR-377 regulates the tumorous behaviors of prostate cancer cells by targeting of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4

sara hajibabaei

Research Square (Research Square), 2023

View PDFchevron_right

Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis

Katherine Tzou, Ravishankar Ram Mani

Cancers, 2020

View PDFchevron_right

MicroRNA Dysregulation in Prostate Cancer

Bogdan Petrut

Pharmacogenomics and Personalized Medicine, 2022

View PDFchevron_right

The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs

Ulrich Brinkmann

Cancer Genomics - Proteomics

View PDFchevron_right

Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer

Gerald Verhaegh

2021

View PDFchevron_right

MicroRNAs and Drug Resistance in Prostate Cancers

Ram Sundar Mahato

Molecular Pharmaceutics, 2014

View PDFchevron_right

The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

Raffaella Giuffrida

Nature Medicine, 2008

View PDFchevron_right

Treating metastatic prostate cancer with microRNA-145

Andre Bordini

Apoptosis : an international journal on programmed cell death, 2018

View PDFchevron_right

miR-377 inhibits the tumorous behavior of prostate cancer cells by targeting MYC

sara hajibabaei

Research Square (Research Square), 2023

View PDFchevron_right

Micrornas in prostate cancer: an overview

Bianca Maria Veneziani

Oncotarget, 2017

View PDFchevron_right

MicroRNA profile analysis of human prostate cancers

Alex Tong

2008

View PDFchevron_right

MicroRNAs as putative mediators of treatment response in prostate cancer

Fardod O'Kelly

Nature reviews. Urology, 2012

View PDFchevron_right

Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis

Valéria Tavares

International Journal of Molecular Sciences

View PDFchevron_right

A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers

Noor Ahmad

Frontiers in Genetics

View PDFchevron_right

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

Annika Fendler

International Journal of Cancer, 2009

View PDFchevron_right

MicroRNA-652 induces NED in LNCaP and EMT in PC3 prostate cancer cells

Arun Seth

Oncotarget, 2018

View PDFchevron_right

MicroRNAs and prostate cancer

Marcello Maugeri-saccà

Endocrine Related Cancer, 2010

View PDFchevron_right

The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer

Nelson Dip

Clinics, 2013

View PDFchevron_right

Downregulation and Prognostic Performance of MicroRNA 224 Expression in Prostate Cancer

Christos K Kontos

Clinical Chemistry, 2013

View PDFchevron_right

Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis

Jinhua Wang

Oncology reports, 2018

View PDFchevron_right

A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions

Ali Amin

View PDFchevron_right

MicroRNAs in prostate cancer: From function to biomarker discovery

Dr Rasha Salah

Experimental biology and medicine (Maywood, N.J.), 2018

View PDFchevron_right